Altimmune Net Tangible Assets from 2010 to 2025
| ALT Stock | USD 5.03 0.25 4.73% |
Net Tangible Assets | First Reported 2011-06-30 | Previous Quarter 155.3 M | Current Value 138 M | Quarterly Volatility 77.4 M |
Check Altimmune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Altimmune's main balance sheet or income statement drivers, such as Interest Expense of 8.6 K, Selling General Administrative of 14 M or Total Revenue of 19 K, as well as many indicators such as Price To Sales Ratio of 26.9 K, Dividend Yield of 23.4 or PTB Ratio of 4.35. Altimmune financial statements analysis is a perfect complement when working with Altimmune Valuation or Volatility modules.
Altimmune | Net Tangible Assets | Build AI portfolio with Altimmune Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.